CAC
BIOT

Cowen and Company’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Cowen and Company’s Portfolio BIOT Stock Details BIOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-150,000
Closed -$1.49M – 747
2022
Q2 		$1.49M Buy
+150,000
New +$1.49M 0.14% 74